StockTipsArenaBeta

BUY Alembic Pharmaceuticals Limited — Sachin Janardan Sarvade, IDBI Capital Markets and Securities

BUYAlembic Pharmaceuticals Limited

bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: NA (inferred Swing (≤2wk))23 Sept 2026via NDTV Profit

Entry₹870Stated
Target₹950
Total upside +9.20%
Stop lossNot given
CMP₹844.45h ago
Active-2.94%+12.51%upside left 13d left
Follow Sachin Janardan Sarvade for new calls(17% target hit, 66 closed calls)Get alertsWatch APLLTD for new buy/sell callsGet alertsSee 1 other Swing call on APLLTDSee 257 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 24 Sept, 4:05 am IST
3 supporting2 neutral0 opposing
Supports the BUY call (3)

MACD above its signal line — bullish momentum

Technicals · macd·23 Sept · today

Past week's volume 2.1× the 30-day average

Technicals · volume·23 Sept · today

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·18 Sept · 5d ago

Neutral / worth noting (2)

Buy, Sell Or Hold: Ather Energy, MCX, Alembic Pharmaceuticals, Power Mech, CESC, Nykaa — Ask Profit

NewsNdtv-Profit·22 Sept · yesterday

(opens in new tab)

Alembic Pharmaceuticals gets USFDA inspection closure for Vadodara bioequivalence facility

NewsCnbc-Tv18·16 Sept · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.